Austin-based neurotechnology Paradromics announced that it has received FDA approvals to start its clinical trials.

Paradromics received regulatory approval to test its BCI device in a small clinical trial to assess its safety and efficacy.

The 2025 Research Innovation Grants are supporting projects focused on biomarkers, risk factors, and treatments for ALS.

A New York-based biotech firm announced it has raised an additional $200 million in financing to advance commercialization of ...

Remember how, last week, we talked about tech giant Microsoft ($MSFT) and its plans to get AI involved in medicine? Well, there are signs that it ...

The first human has received Neuralink’s brain-computer interface, which company founder Elon Musk has claimed could one day help the blind see, restore mobility to people with severe paralysis and ...

Brain-computer interfaces are a groundbreaking technology that can help paralyzed people regain functions they’ve lost, like moving a hand. These devices record signals from the brain and decipher the ...

Brain-computer interface technology uses the fact that the brain communicates with itself and with the outside world using electrical signals. And so brain-computer interfaces are implants that use ...

The ability of these devices to access aspects of a person’s innermost life, including preconscious thought, raises the ...

Instead, through the fund that bears their name, they have helped raise more than $550 million for The Miami Project to Cure ...

Engineering researchers have invented an advanced brain-computer interface with a flexible and moldable backing and penetrating microneedles. Adding a flexible backing to this kind of brain-computer ...